Relmada Therapeutics Inc.

NASDAQ: RLMD · Real-Time Price · USD
0.61
-0.01 (-1.79%)
At close: Aug 20, 2025, 10:13 AM

Relmada Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-9.87M -17.56M -18.66M -21.73M -17.77M -21.83M -25.17M -22M -25.3M -26.32M -37.94M -39.42M -39.93M -39.75M -34.38M -42.61M -26.55M -22.22M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 452.00 806.00
Stock-Based Compensation
3.45M 4.48M 6.72M 7.95M 7.21M 8.3M 9.89M 11.39M 11.17M 11.35M 11.63M 8.34M 12.3M 11.93M 18.36M 8.01M 8.27M 5.85M
Other Working Capital
-47.38K -1.9M 1.11M 3.85M -1.61M -1.08M 4.78M 343.99K -211.12K -73.61K -4.76M -182.58K 7.98M 7.13M -10.24M 931.45K -1.71M 311.34K
Other Non-Cash Items
-33.41K -218.68K 236.22K -4.9M -87.65K -103.85K -404.94K 630.86K 639.63K -624.4K -6M 7.86M -5.19M 1.78M -9.89M 10.49M 412.87K 229.95K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
49.52K -4.77M 2.9M 2.02M -2.62M 599.76K 5.43M -1.65M 220.53K -913.58K -3.57M -3.65M 11.2M 6.61M -11.76M 3.18M 658.83K 47.66K
Operating Cash Flow
-6.4M -18.07M -8.8M -16.66M -13.26M -13.04M -10.25M -11.63M -13.27M -16.51M -35.88M -26.86M -21.63M -19.43M -37.66M -20.92M -17.21M -16.09M
Capital Expenditures
-4 3.00 4.00 n/a 5.00 n/a 4.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-321.46K -487.92K -654.64K -3.11M -1.3M -7.01M -33.31M -11.57M -10.81M -34.77M -8.3M -5.58M -7.5M -25.92M -140.51M -25.6M -36.21M -20.66M
Sales Maturities Of Investments
7M 15.85M 12M 19.26M 15.31M 17.07M 41.05M 15.43M 9.66M 74.77M 6.65M 37.14M 7.36M 15.89M 49.32M 53.12M 30.3M 36.13M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a -1.15K 40K -1.66K 31.56K -140.52 -10.03K -91.18K 27.51K -5.91K 15.46K
Investing Cash Flow
6.68M 15.36M 11.35M 16.14M 14.01M 10.06M 7.74M 3.86M -1.15M 40M -1.66M 31.56M -140.52K -10.03M -91.18M 27.51M -5.91M 15.47M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-73.02K n/a -172.49K -89.6K n/a -25K -98.46K n/a n/a n/a 409.88K -134.63K 948.09K 364.81K 511.09K 175.01K 481.45K 1.46M
Financial Cash Flow
-73.02K n/a -172.49K -89.6K n/a 221.75K -98.46K n/a n/a n/a 409.88K 569.09K 14.09M 29.95M 161.84M 185.16K 23.99M 1.93M
Net Cash Flow
203.65K -2.71M 2.37M -602.47K 751.24K -2.76M -2.61M -7.77M -14.43M 23.5M -37.13M 5.26M -7.67M 490.94K 32.99M 6.78M 865.3K 1.31M
Free Cash Flow
-6.4M -18.07M -8.8M -16.66M -13.26M -13.04M -10.25M -11.63M -13.27M -16.51M -35.88M -26.86M -21.63M -19.43M -37.66M -20.92M -17.21M -16.09M